[go: up one dir, main page]

NO995075L - Steroid-sulfataseinhibitorer - Google Patents

Steroid-sulfataseinhibitorer

Info

Publication number
NO995075L
NO995075L NO995075A NO995075A NO995075L NO 995075 L NO995075 L NO 995075L NO 995075 A NO995075 A NO 995075A NO 995075 A NO995075 A NO 995075A NO 995075 L NO995075 L NO 995075L
Authority
NO
Norway
Prior art keywords
sub
compound
enzyme
sulphate
steroid sulphatase
Prior art date
Application number
NO995075A
Other languages
English (en)
Other versions
NO995075D0 (no
NO308903B1 (no
Inventor
Michael John Reed
Barry Victor Lloyd Potter
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO995075L publication Critical patent/NO995075L/no
Application filed by Sterix Ltd filed Critical Sterix Ltd
Publication of NO995075D0 publication Critical patent/NO995075D0/no
Publication of NO308903B1 publication Critical patent/NO308903B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Surgical Instruments (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO995075A 1991-08-29 1999-10-18 Steroid-sulfataseinhibitorer NO308903B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919118478A GB9118478D0 (en) 1991-08-29 1991-08-29 Steroid sulphatase inhibitors
PCT/GB1992/001587 WO1993005064A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors

Publications (3)

Publication Number Publication Date
NO995075L true NO995075L (no) 1994-04-29
NO995075D0 NO995075D0 (no) 1999-10-18
NO308903B1 NO308903B1 (no) 2000-11-13

Family

ID=10700604

Family Applications (6)

Application Number Title Priority Date Filing Date
NO940635A NO307301B1 (no) 1991-08-29 1994-02-24 Anvendelse av en forbindelse for fremstilling av et medikament for å inhibere steroidsulfataseaktivitet
NO995075A NO308903B1 (no) 1991-08-29 1999-10-18 Steroid-sulfataseinhibitorer
NO995076A NO308774B1 (no) 1991-08-29 1999-10-18 Farmasøytisk preparat
NO20002595A NO314287B1 (no) 1991-08-29 2000-05-19 Anvendelse av en ringsystemforbindelse for fremstilling av et medikament
NO20025725A NO318009B1 (no) 1991-08-29 2002-11-28 Forbindelse, farmasoytisk preparat inneholdende den samme samt anvendelse derav
NO20044458A NO20044458L (no) 1991-08-29 2004-10-20 Anvendelse av en ringsystemforbindelse for fremstilling av et medikament

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO940635A NO307301B1 (no) 1991-08-29 1994-02-24 Anvendelse av en forbindelse for fremstilling av et medikament for å inhibere steroidsulfataseaktivitet

Family Applications After (4)

Application Number Title Priority Date Filing Date
NO995076A NO308774B1 (no) 1991-08-29 1999-10-18 Farmasøytisk preparat
NO20002595A NO314287B1 (no) 1991-08-29 2000-05-19 Anvendelse av en ringsystemforbindelse for fremstilling av et medikament
NO20025725A NO318009B1 (no) 1991-08-29 2002-11-28 Forbindelse, farmasoytisk preparat inneholdende den samme samt anvendelse derav
NO20044458A NO20044458L (no) 1991-08-29 2004-10-20 Anvendelse av en ringsystemforbindelse for fremstilling av et medikament

Country Status (25)

Country Link
US (3) US5616574A (no)
EP (6) EP1522543A1 (no)
JP (6) JP3219408B2 (no)
KR (4) KR100258396B1 (no)
AT (5) ATE237333T1 (no)
AU (2) AU689043B2 (no)
BR (1) BR9206434A (no)
CA (4) CA2114630C (no)
CY (4) CY2253B1 (no)
CZ (1) CZ295939B6 (no)
DE (5) DE69231280T2 (no)
DK (4) DK0982032T3 (no)
ES (4) ES2204059T3 (no)
FI (5) FI940903A7 (no)
GB (1) GB9118478D0 (no)
GE (6) GEP20022766B (no)
GR (1) GR3034579T3 (no)
HU (1) HUT66097A (no)
LV (1) LV12618B (no)
NO (6) NO307301B1 (no)
RU (4) RU2182152C2 (no)
SG (7) SG106116A1 (no)
SK (4) SK282187B6 (no)
UA (4) UA41875C2 (no)
WO (1) WO1993005064A1 (no)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9625334D0 (en) * 1996-12-05 1997-01-22 Imperial College Compound
GB9604709D0 (en) * 1996-03-05 1996-05-01 Imperial College A compound
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US6011024A (en) * 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6903084B2 (en) * 1991-08-28 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
GB9603325D0 (en) 1996-02-16 1996-04-17 Imperial College A compound
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
AU2112995A (en) * 1994-04-05 1995-10-23 Celltech Therapeutics Limited Use of estrone derivatives as steroid sulphatase inhibitors
DE4429398C2 (de) * 1994-08-09 1997-09-11 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
DE4429397C2 (de) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
GB9422777D0 (en) * 1994-11-11 1995-01-04 Imperial College Assay
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US5705495A (en) * 1995-10-19 1998-01-06 Jenapharm Gmbh & Co. Kg. Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, methods for their production and pharmaceuticals containing these compounds
US6921776B1 (en) 1996-02-16 2005-07-26 Sterix Limited Compound
US6506792B1 (en) 1997-03-04 2003-01-14 Sterix Limited Compounds that inhibit oestrone sulphatase and/or aromatase and methods for making and using
ATE286038T1 (de) * 1996-03-05 2005-01-15 Sterix Ltd Verbindungen mit sulfonsäure-amidgruppe
US6087347A (en) * 1996-09-12 2000-07-11 Teikoku Hormone Mfg. Co., Ltd. 3-substituted-D-homo-1,3,5(10)-estratriene derivatives
US6642220B1 (en) 1996-12-05 2003-11-04 Sterix Limited Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same
US20040127473A1 (en) * 1996-12-05 2004-07-01 Reed Michael John Compound
US5763432A (en) * 1997-01-29 1998-06-09 Sri International Steriod inhibitors of estrone sulfatase and associated pharmaceutical compositions and methods of use
DE19712488A1 (de) 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
GB9708716D0 (en) * 1997-04-29 1997-06-18 Imperial College Chronic heart failure
US6288050B1 (en) * 1997-07-18 2001-09-11 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6376687B1 (en) 1997-07-18 2002-04-23 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US5880115A (en) * 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
GB2331988B (en) 1997-12-04 2003-04-16 Imperial College Polycyclic sulphamate inhibitors or oestrone sulphatase
GB2331987B (en) * 1997-12-04 2002-11-27 Imperial College Polycyclic sulphamate inhibitors of oestrone sulphatase
US6046186A (en) * 1997-12-24 2000-04-04 Sri International Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
GB9807779D0 (en) 1998-04-09 1998-06-10 Ciba Geigy Ag Organic compounds
WO1999061055A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
ES2310943T3 (es) * 1998-06-10 2009-01-16 Sterix Limited Composicion farmaceutica con factor de necrosis tumoral a y 2-metoxiestrona-3-o-sulfamato para la inhibicion de la estrona sulfatasa.
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
WO2000053620A1 (en) * 1999-03-10 2000-09-14 Nippon Organon K. K. Novel estradiol derivatives
JP2000309599A (ja) 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−１，３，５（１０），１６−テトラエン誘導体
US7078395B1 (en) 1999-06-16 2006-07-18 Sterix Limited Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling
WO2000066095A2 (en) 1999-04-30 2000-11-09 Sterix Limited Use of estrone derivatives as antitumour agents
AU2005225148B2 (en) * 1999-04-30 2008-04-03 Sterix Limited Use
GB9913536D0 (en) * 1999-06-10 1999-08-11 Sterix Ltd Use
US6583130B1 (en) 1999-09-13 2003-06-24 Schering Ag C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds
AU2190601A (en) 1999-12-13 2001-06-25 Sterix Limited Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
AU2001248849A1 (en) * 2000-04-24 2001-11-07 Kyowa Hakko Kogyo Co. Ltd. Estra-1,3,5(10)-triene derivatives
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
GB0020498D0 (en) * 2000-08-18 2000-10-11 Sterix Ltd Compound
EP1406634A1 (en) 2001-07-13 2004-04-14 Schering Aktiengesellschaft Combination of drospirenone and an estrogen sulphamate for hrt
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US8026229B2 (en) 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
DE10139494A1 (de) * 2001-08-13 2003-03-06 Jenapharm Gmbh Antitumor wirksame 2-Alkoxyestradiolsulfamate
DE60229009D1 (de) 2001-10-18 2008-10-30 Sterix Ltd Steroidale Verbindungen zur Hemmung von steroid Sulfotase
PT1448592E (pt) * 2001-10-18 2006-07-31 Sterix Ltd Compostos esteroides para inibicao da esteroide sulfatase
US20040254241A1 (en) * 2002-08-28 2004-12-16 Yoji Ino Aryl sulfamate derivatives
EP1568381A1 (en) * 2002-10-09 2005-08-31 Kyowa Hakko Kogyo Co., Ltd. Remedy for hormone-dependent cancer
DE10307103A1 (de) 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
DE10307104A1 (de) 2003-02-19 2004-09-23 Schering Ag Antitumor wirksame 2-substituierte Estra-1,3,5(10)-trien-3-yl sulfamate
DE10307105A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte 18a-Homoestra-1,3,5(10)-trien-3-yl sulfamate
BR0318295A (pt) * 2003-05-16 2006-07-11 Theramex derivados de sulfamato de benzotiofeno utilizados como inibidores da esteróide sulfatase
DE602004026571D1 (en) * 2003-05-21 2010-05-27 Aska Pharm Co Ltd Cyclisches aminophenylsulfamatderivativ
TWI331154B (en) * 2003-11-12 2010-10-01 Solvay Pharm Gmbh Novel 17-hydroxysteroid dehydrogenase type i inhibitors
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
GB0412492D0 (en) 2004-06-04 2004-07-07 Sterix Ltd Compound
CA2789097C (en) 2005-04-28 2017-02-21 Proteus Digital Health, Inc. Pharma-informatics system
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
GB0624105D0 (en) * 2006-12-01 2007-01-10 Sterix Ltd Use
GB0706072D0 (en) 2007-03-28 2007-05-09 Sterix Ltd Compound
JP5543920B2 (ja) 2007-09-17 2014-07-09 プレグレム エスアー 閉経前の女性におけるエストロゲン依存症状の治療
EP2149371A1 (en) * 2008-07-28 2010-02-03 PregLem S.A. Use of steroid sulfatase inhibitors for the treatment of preterm labor
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
GB0914767D0 (en) 2009-08-24 2009-09-30 Sterix Ltd Compound
CN110974840A (zh) * 2019-12-27 2020-04-10 天津市肿瘤医院 一种类固醇硫酸酯酶抑制剂及其药物用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE114806C (no) *
DE1593846A1 (de) * 1967-01-28 1971-02-25 Hoechst Ag Verfahren zur Herstellung von Sulfamidsaeure-arylestern
US3647738A (en) * 1970-11-03 1972-03-07 Union Carbide Corp Alpha-olefin polymer compositions
GB1398026A (en) * 1972-11-10 1975-06-18 Jenapharm Veb Steroid esters
DE2418217A1 (de) * 1974-04-13 1975-11-06 Hoechst Ag Sulfamidsaeureester und verfahren zu ihrer herstellung
DD114806A1 (no) * 1974-10-11 1975-08-20
US4810700A (en) * 1978-10-18 1989-03-07 Wayne State University Compositions inhibiting estrogen sulfotransferase activity
US4340602A (en) * 1978-10-18 1982-07-20 Wayne State University Compositions inhibiting estrogen sulfotransferase activity
US4937237A (en) * 1988-12-23 1990-06-26 Smithkline Beckman Corporation Phosphinic acid substituted aromatic steroids as inhibitors of steroid 5-60 -reductase
PT94305B (pt) * 1989-06-12 1997-02-28 Robins Co Inc A H Processo para a preparacao de compostos tendo um ou mais radicais aminossulfoniloxi uteis como produtos farmaceuticos
GB9003939D0 (en) * 1990-02-21 1990-04-18 Imperial College Sulphatase inhibitors
GB9625334D0 (en) * 1996-12-05 1997-01-22 Imperial College Compound
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9603325D0 (en) * 1996-02-16 1996-04-17 Imperial College A compound
GB9118465D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19540233B4 (de) * 1995-10-19 2005-08-25 Schering Ag Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
ATE286038T1 (de) * 1996-03-05 2005-01-15 Sterix Ltd Verbindungen mit sulfonsäure-amidgruppe
US5880115A (en) * 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same

Also Published As

Publication number Publication date
US6159960A (en) 2000-12-12
ATE237333T1 (de) 2003-05-15
KR100321018B1 (ko) 2002-03-20
KR100322650B1 (ko) 2002-03-20
JP3581821B2 (ja) 2004-10-27
RU2182152C2 (ru) 2002-05-10
DE69231280D1 (de) 2000-08-24
FI20050991L (fi) 2005-10-03
GEP20022802B (en) 2002-09-25
CA2305749A1 (en) 1993-03-18
US5830886A (en) 1998-11-03
DE69233149T2 (de) 2004-06-24
ES2204059T3 (es) 2004-04-16
NO20025725D0 (no) 2002-11-28
FI20002260A7 (fi) 2000-10-13
DK0921130T3 (da) 2003-07-21
GR3034579T3 (en) 2001-01-31
EP1522543A1 (en) 2005-04-13
GEP20063773B (en) 2006-03-27
NO940635D0 (no) 1994-02-24
NO20044458L (no) 1994-04-29
US5616574A (en) 1997-04-01
NO940635L (no) 1994-04-29
SK282186B6 (sk) 2001-12-03
FI20002259A7 (fi) 2000-10-13
CZ44094A3 (en) 1995-01-18
CY2397B1 (en) 2004-09-10
DE69233020T2 (de) 2003-11-06
GEP20022766B (en) 2002-08-26
HK1020672A1 (en) 2000-05-19
JP2003176297A (ja) 2003-06-24
FI940903A0 (fi) 1994-02-25
EP0641355B1 (en) 2000-07-19
LV12618B (en) 2001-07-20
JP3581820B2 (ja) 2004-10-27
NO995075D0 (no) 1999-10-18
NO2595A (no) 1994-04-29
DE69233431T2 (de) 2006-02-23
EP0928609A2 (en) 1999-07-14
GEP20022637B (en) 2002-02-25
SG88782A1 (en) 2002-05-21
UA70957C2 (uk) 2004-11-15
DK0982032T3 (da) 2003-11-03
EP0982032A3 (en) 2002-03-20
FI20002260L (fi) 2000-10-13
RU2207134C2 (ru) 2003-06-27
SG88783A1 (en) 2002-05-21
CA2114630C (en) 2003-09-30
AU689043B2 (en) 1998-03-19
ATE246706T1 (de) 2003-08-15
AU717116B2 (en) 2000-03-16
FI20002261L (fi) 2000-10-13
HK1025051A1 (en) 2000-11-03
DE69233053D1 (de) 2003-06-12
HK1019753A1 (en) 2000-02-25
ES2148178T3 (es) 2000-10-16
SG103820A1 (en) 2004-05-26
NO20002595D0 (no) 2000-05-19
KR100258396B1 (ko) 2000-08-01
CA2114630A1 (en) 1993-03-18
SG103374A1 (en) 2004-04-29
EP1099706A2 (en) 2001-05-16
SK282187B6 (sk) 2001-12-03
NO308774B1 (no) 2000-10-30
JP2002255993A (ja) 2002-09-11
JP3219408B2 (ja) 2001-10-15
EP0982032B1 (en) 2003-08-06
GEP20033094B (en) 2003-10-27
FI20050991A7 (fi) 2005-10-03
EP0928609A3 (en) 2001-11-07
FI940903A7 (fi) 1994-04-20
NO995076L (no) 1994-04-29
CA2305758A1 (en) 1993-03-18
ES2196483T3 (es) 2003-12-16
BR9206434A (pt) 1994-09-27
ES2193475T3 (es) 2003-11-01
CZ295939B6 (cs) 2005-12-14
AU1007799A (en) 1999-03-04
SK282189B6 (sk) 2001-12-03
UA41875C2 (uk) 2001-10-15
NO307301B1 (no) 2000-03-13
SG115508A1 (en) 2005-10-28
SG106116A1 (en) 2004-09-30
NO308903B1 (no) 2000-11-13
RU94019334A (ru) 1996-10-20
UA70958C2 (uk) 2004-11-15
JP2000355598A (ja) 2000-12-26
EP0921130B1 (en) 2003-05-07
NO20025725L (no) 1994-04-29
CY2253B1 (en) 2003-07-04
GEP20022803B (en) 2002-09-25
DE69233053T2 (de) 2003-11-20
NO318009B1 (no) 2005-01-17
GB9118478D0 (en) 1991-10-16
SK282188B6 (sk) 2001-12-03
EP0921130A3 (en) 2001-09-05
DK0928609T3 (da) 2003-07-21
AU2490592A (en) 1993-04-05
CY2394B1 (en) 2004-09-10
SG73391A1 (en) 2006-08-30
DE69231280T2 (de) 2000-11-30
ATE194843T1 (de) 2000-08-15
EP1099706A3 (en) 2002-09-04
WO1993005064A1 (en) 1993-03-18
LV12618A (en) 2001-02-20
FI20002259L (fi) 2000-10-13
EP0641355A1 (en) 1995-03-08
FI20002261A7 (fi) 2000-10-13
HU9400583D0 (en) 1994-05-30
CA2305767A1 (en) 1993-03-18
DE69233020D1 (de) 2003-05-22
JP2000355542A (ja) 2000-12-26
SK24694A3 (en) 1994-11-09
EP1099706B1 (en) 2004-10-06
RU2001125673A (ru) 2003-06-27
HUT66097A (en) 1994-09-28
JP3581802B2 (ja) 2004-10-27
NO995076D0 (no) 1999-10-18
EP0921130A2 (en) 1999-06-09
JP2000038341A (ja) 2000-02-08
NO314287B1 (no) 2003-03-03
RU2210574C2 (ru) 2003-08-20
EP0982032A2 (en) 2000-03-01
KR100321019B1 (ko) 2002-03-20
ATE239753T1 (de) 2003-05-15
DE69233431D1 (de) 2004-11-11
DK0641355T3 (da) 2000-10-09
ATE278704T1 (de) 2004-10-15
AU668882B2 (en) 1996-05-23
UA70956C2 (uk) 2004-11-15
CY2398B1 (en) 2004-09-10
JPH07501515A (ja) 1995-02-16
DE69233149D1 (de) 2003-09-11
EP0928609B1 (en) 2003-04-16
AU5837396A (en) 1996-09-05

Similar Documents

Publication Publication Date Title
NO308903B1 (no) Steroid-sulfataseinhibitorer